Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Analysis of legal and scientific issues in court challenges to graphic tobacco warnings.

Kraemer JD, Baig SA.

Am J Prev Med. 2013 Sep;45(3):334-42. doi: 10.1016/j.amepre.2013.05.004.

PMID:
23953361
2.

The FDA and graphic cigarette-pack warnings--thwarted by the courts.

Bayer R, Johns D, Colgrove J.

N Engl J Med. 2013 Jul 18;369(3):206-8. doi: 10.1056/NEJMp1306205. Epub 2013 Jun 26. No abstract available.

3.

Required warnings for cigarette packages and advertisements. Final rule.

Food and Drug Administration, HHS..

Fed Regist. 2011 Jun 22;76(120):36628-777.

4.

The FDA's graphic tobacco warnings and the first amendment.

Orentlicher D.

N Engl J Med. 2013 Jul 18;369(3):204-6. doi: 10.1056/NEJMp1304513. Epub 2013 Jun 26. No abstract available.

5.
6.

FDA withdraws from fight over graphic warning labels on cigarette packs.

Printz C.

Cancer. 2013 Jul 1;119(13):2361. doi: 10.1002/cncr.28206. No abstract available.

7.

Indian anti-tobacco campaigners plead for larger graphic warnings on products.

Bagcchi S.

BMJ. 2015 Apr 10;350:h1939. doi: 10.1136/bmj.h1939. No abstract available.

PMID:
25862697
8.

Single Cigarette Sales: State Differences in FDA Advertising and Labeling Violations, 2014, United States.

Baker HM, Lee JG, Ranney LM, Goldstein AO.

Nicotine Tob Res. 2016 Feb;18(2):221-6. doi: 10.1093/ntr/ntv053. Epub 2015 Mar 5.

9.

The effect of graphic cigarette warning labels on smoking behavior: evidence from the Canadian experience.

Azagba S, Sharaf MF.

Nicotine Tob Res. 2013 Mar;15(3):708-17. doi: 10.1093/ntr/nts194. Epub 2012 Sep 18. Erratum in: Nicotine Tob Res. 2013 May;15(5):1000-2.

PMID:
22990228
10.

Public support for graphic health warning labels in the U.S.

Kamyab K, Nonnemaker JM, Farrelly MC.

Am J Prev Med. 2015 Jan;48(1):89-92. doi: 10.1016/j.amepre.2014.07.032. Epub 2014 Sep 11.

PMID:
25217818
11.

Expressive freedom and tobacco advertising: a Canadian perspective.

Manfredi CP.

Am J Public Health. 2002 Mar;92(3):360-2.

12.

Smokers' recall of Australian graphic cigarette packet warnings & awareness of associated health effects, 2005-2008.

Miller CL, Quester PG, Hill DJ, Hiller JE.

BMC Public Health. 2011 Apr 17;11:238. doi: 10.1186/1471-2458-11-238.

13.

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.

Chaloupka FJ, Warner KE, Acemoğlu D, Gruber J, Laux F, Max W, Newhouse J, Schelling T, Sindelar J.

Tob Control. 2015 Mar;24(2):112-9. doi: 10.1136/tobaccocontrol-2014-052022. Epub 2014 Dec 30.

14.

Tobacco under the FDA: a summary of the Family Smoking Prevention and Tobacco Control Act.

Lundeen RE Jr.

Health Care Law Mon. 2009 Sep;2009(9):2-9. No abstract available.

PMID:
19771935
15.

[Pictorial health warnings on tobacco products packages as a part of tobacco epidemic control].

Kaleta D, Kozieł A, Miśkiewicz P.

Med Pr. 2009;60(5):399-403. Polish.

PMID:
19999044
17.

The butt stops here: the Tobacco Control Act's anti-smoking regulations run afoul of the First Amendment.

Weatherby D, Day TR.

Albany Law Rev. 2012-2013;76(1):121-65. No abstract available.

PMID:
23577376
18.

FDA regulation of tobacco: blessing or curse for FDA professionals?

O'Reilly JT.

Food Drug Law J. 2009;64(3):459-72.

PMID:
19999639
19.
20.

Response of mass media, tobacco industry and smokers to the introduction of graphic cigarette pack warnings in Australia.

Miller CL, Hill DJ, Quester PG, Hiller JE.

Eur J Public Health. 2009 Dec;19(6):644-9. doi: 10.1093/eurpub/ckp089. Epub 2009 Jul 9.

PMID:
19589850

Supplemental Content

Support Center